Literature DB >> 33115863

Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.

Marcel Chris Conrady1, Irina Suarez2, Gergö Gogl2, Desiree Isabella Frecot1, Anna Bonhoure2, Camille Kostmann2, Alexandra Cousido-Siah2, André Mitschler2, JiaWen Lim1, Murielle Masson3, Thomas Iftner1, Frank Stubenrauch1, Gilles Travé4, Claudia Simon5.   

Abstract

The degradation of p53 is a hallmark of high-risk human papillomaviruses (HPVs) of the alpha genus and HPV-related carcinogenicity. The oncoprotein E6 forms a ternary complex with the E3 ubiquitin ligase E6-associated protein (E6AP) and tumor suppressor protein p53 targeting p53 for ubiquitination. The extent of p53 degradation by different E6 proteins varies greatly, even for the closely related HPV16 and HPV31. HPV16 E6 and HPV31 E6 display high sequence identity (∼67%). We report here, for the first time, the structure of HPV31 E6 bound to the LxxLL motif of E6AP. HPV16 E6 and HPV31 E6 are structurally very similar, in agreement with the high sequence conservation. Both E6 proteins bind E6AP and degrade p53. However, the binding affinities of 31 E6 to the LxxLL motif of E6AP and p53, respectively, are reduced 2-fold and 5.4-fold compared to 16 E6. The affinity of E6-E6AP-p53 ternary complex formation parallels the efficacy of the subsequent reaction, namely, degradation of p53. Therefore, closely related E6 proteins addressing the same cellular targets may still diverge in their binding efficiencies, possibly explaining their different phenotypic or pathological impacts.IMPORTANCE Variations of carcinogenicity of human papillomaviruses are related to variations of the E6 and E7 interactome. While different HPV species and genera are known to target distinct host proteins, the fine differences between E6 and E7 of closely related HPVs, supposed to target the same cellular protein pools, remain to be addressed. We compare the oncogenic E6 proteins of the closely related high-risk HPV31 and HPV16 with regard to their structure and their efficiency of ternary complex formation with their cellular targets p53 and E6AP, which results in p53 degradation. We solved the crystal structure of 31 E6 bound to the E6AP LxxLL motif. HPV16 E6 and 31 E6 structures are highly similar, but a few sequence variations lead to different protein contacts within the ternary complex and, as quantified here, an overall lower binding affinity of 31 E6 than 16 E6. These results align with the observed lower p53 degradation potential of 31 E6.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  E6; E6AP; oncogens; p53; papillomavirus; tumor virus

Mesh:

Substances:

Year:  2020        PMID: 33115863      PMCID: PMC7944444          DOI: 10.1128/JVI.00730-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Human papillomaviruses.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  2007

2.  p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes.

Authors:  Thibault Mesplède; David Gagnon; Fanny Bergeron-Labrecque; Ibrahim Azar; Hélène Sénéchal; François Coutlée; Jacques Archambault
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 3.  Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic Review.

Authors:  Andrew P Stein; Sandeep Saha; Jennifer L Kraninger; Adam D Swick; Menggang Yu; Paul F Lambert; Randall J Kimple
Journal:  Cancer J       Date:  2015 May-Jun       Impact factor: 3.360

4.  XDS.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

5.  Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

Authors:  Nubia Muñoz; F Xavier Bosch; Xavier Castellsagué; Mireia Díaz; Silvia de Sanjose; Doudja Hammouda; Keerti V Shah; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

6.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; R D Vierstra; P M Howley
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

7.  Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity.

Authors:  L V Ronco; A Y Karpova; M Vidal; P M Howley
Journal:  Genes Dev       Date:  1998-07-01       Impact factor: 11.361

8.  Novel microscale approaches for easy, rapid determination of protein stability in academic and commercial settings.

Authors:  Crispin G Alexander; Randy Wanner; Christopher M Johnson; Dennis Breitsprecher; Gerhard Winter; Stefan Duhr; Philipp Baaske; Neil Ferguson
Journal:  Biochim Biophys Acta       Date:  2014-09-28

Review 9.  Why Human Papillomaviruses Activate the DNA Damage Response (DDR) and How Cellular and Viral Replication Persists in the Presence of DDR Signaling.

Authors:  Molly L Bristol; Dipon Das; Iain M Morgan
Journal:  Viruses       Date:  2017-09-21       Impact factor: 5.048

10.  Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus.

Authors:  Hye-Yeoung Yun; Min Wook Kim; Hye Seon Lee; Wantae Kim; Ji Hye Shin; Hyunmin Kim; Ho-Chul Shin; Hwangseo Park; Byung-Ha Oh; Won Kon Kim; Kwang-Hee Bae; Sang Chul Lee; Eun-Woo Lee; Bonsu Ku; Seung Jun Kim
Journal:  PLoS Biol       Date:  2019-07-19       Impact factor: 8.029

View more
  6 in total

1.  Activating transcription factor 3 mediates apoptotic functions through a p53-independent pathway in human papillomavirus 18 infected HeLa cells.

Authors:  Abolfazl Kooti; Haniyeh Abuei; Ali Farhadi; Abbas Behzad-Behbahani; Maryam Zarrabi
Journal:  Virus Genes       Date:  2022-02-07       Impact factor: 2.332

Review 2.  The Autophagy Process in Cervical Carcinogenesis: Role of Non-Coding-RNAs, Molecular Mechanisms, and Therapeutic Targets.

Authors:  Alfredo Lagunas-Martínez; Vicente Madrid-Marina; Claudia Gómez-Cerón; Jessica Deas; Oscar Peralta-Zaragoza
Journal:  Cells       Date:  2022-04-13       Impact factor: 7.666

3.  siRNA-Inhibition of TIGAR Hypersensitizes Human Papillomavirus-Transformed Cells to Apoptosis Induced by Chemotherapy Drugs that Cause Oxidative Stress.

Authors:  Lacin Yapindi; Brenda Y Hernandez; Robert Harrod
Journal:  J Antivir Antiretrovir       Date:  2021-05-31

4.  An enhanced triple fluorescence flow-cytometry-based assay shows differential activation of the Notch signaling pathway by human papillomavirus E6 proteins.

Authors:  JiaWen Lim; Elke Straub; Frank Stubenrauch; Thomas Iftner; Michael Schindler; Claudia Simon
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

5.  The RBPJ/DAPK3/UBE3A signaling axis induces PBRM1 degradation to modulate the sensitivity of renal cell carcinoma to CDK4/6 inhibitors.

Authors:  Wentao Liu; Bin Zhang; Dan Zhang; Feng Guo; Kun Ye; Liang Zhu; Xin Jin
Journal:  Cell Death Dis       Date:  2022-04-02       Impact factor: 8.469

Review 6.  Metabolic Control by DNA Tumor Virus-Encoded Proteins.

Authors:  Martin A Prusinkiewicz; Joe S Mymryk
Journal:  Pathogens       Date:  2021-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.